Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGG492 monotherapy in refractory partial seizures during presurgical epilepsy evaluation
2008-005065-64Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Focal Onset Epilepsy comparing BGG492 monotherapy with Placebo (2 arms). Primary endpoint: Pharmacodynamic assessments. Started Dec 2008; status: completed.
02
Drugs
selurampanel
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2008-005065-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005065-64.